Public Health Europe - European Commission - EU

Advanced therapy medicinal products (ATMPs): DG SANTE and EMA launch new action plan (20.10.2017)

Today the Commission services and the European Medical Agency (EMA) have launched a joint action plan to foster the development of advanced therapy medicinal products (ATMPs), with the aim of streamlining the procedures and better addressing the specific requirements of ATMPs developers.

Aluminium in Toys – Final scientific opinion published (20.10.2017)

The Scientific Committee on Health, Environmental and merging Risks (SCHEER) - Commission's independent scientific committee - published its final Opinion on tolerable intake of aluminium in order to determine the acceptable levels of aluminium counts in toys.

'Health in the digital society' conference, Tallinn, 17 October 2017 (17.10.2017)

Message from Vytenis Andriukaitis, European Commissioner for Health and Food Safety

HIV and Hepatitis C epidemics progression in the EU: 3rd Partnership Forum organised by the joint action HA-REACT (26-27 October 2017) (16.10.2017)

The Joint Action on HIV and Co-infection Prevention and Harm Reduction (HA-REACT) addresses existing gaps in the prevention of HIV and other co-infections, especially tuberculosis and viral hepatitis, among people who inject drugs. The 3rd partnership forum will take place on 26 and 27 October 2017.

Health-EU Newsletter: Unequalled efforts to ensure equal access to healthcare (12.10.2017)

European Commission Director General for Health and Food Safety Xavier Prats Monné speaks about the Commission's efforts to improve the health of migrants and refugees, while helping Member States to strengthen their health systems to become more accessible, effective and resilient.

Steering EU Public Health

Ensuring health security

Improving health systems

Risk assessment

Taking Action against Diseases

Health in Society

Fostering good health

Indicators and data

Pharmaceuticals

Endocrine disruptors

Endocrine disruptors

Biocides

Biocides